Physician
White Oak Pediatrics DRS Battiata & Impeduglia PA
White Oak Pediatrics DRS Battiata & Impeduglia PA was paid $12.30M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoWHITE OAK PEDIATRICS DRS BATTIATA & IMPEDUGLIA PA
SILVER SPRING, MD 20904
SILVER SPRING, MD 20904
33aNPI1710139316assigned 10/15/2008
33bProvider typePediatrics Physician
28Total paid$12.30M
24GClaims332,112
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#6 of 306
Median peer was paid$206K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,490 | $44K | |
| 2019 | 797 | $30K | |
| 2020 | 51,435 | $1.98M | |
| 2021 | 58,041 | $2.09M | |
| 2022 | 74,961 | $2.84M | |
| 2023 | 79,041 | $2.93M | |
| 2024incomplete | 66,347 | $2.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 41,639 | 37,533 | $3.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 14,012 | 12,949 | $1.76M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.0% | 9,150 | 8,821 | $990K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.4% | 7,627 | 7,390 | $905K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.9% | 7,896 | 7,566 | $850K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.2% | 6,372 | 5,648 | $635K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 10,692 | 9,983 | $463K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.9% | 6,686 | 6,235 | $357K |
| 90686 | 2.1% | 11,196 | 10,827 | $254K | |
| 92551 | 1.8% | 23,103 | 22,354 | $219K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.3% | 4,620 | 4,417 | $160K |
| 99381 | 1.1% | 1,325 | 1,219 | $141K |
91 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 12,989 | $136K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 999 | $110K |
| 90648 | <1% | 4,109 | $92K | |
| 99177 | <1% | 15,568 | $78K | |
| 90670 | <1% | 3,192 | $72K | |
| 96161 | <1% | 26,524 | $68K | |
| 90723 | <1% | 2,940 | $66K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,142 | $65K |
| 90651 | <1% | 2,834 | $65K | |
| D1206 | Topical application of fluoride varnish | <1% | 2,605 | $64K |
| 99383 | <1% | 510 | $61K | |
| 90680 | <1% | 2,636 | $59K | |
| 96127 | <1% | 12,487 | $58K | |
| 90633 | <1% | 2,582 | $58K | |
| 99173 | <1% | 17,002 | $41K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,787 | $40K |
| 90620 | <1% | 1,466 | $39K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,864 | $34K |
| 96160 | <1% | 11,884 | $33K | |
| 99070 | <1% | 4,401 | $32K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,137 | $29K |
| 0071A | <1% | 737 | $28K | |
| 90734 | <1% | 1,191 | $27K | |
| 90715 | <1% | 1,182 | $27K | |
| 99384 | <1% | 204 | $27K | |
| 90656 | <1% | 1,091 | $25K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,475 | $24K |
| 90716 | <1% | 1,068 | $24K | |
| 0072A | <1% | 600 | $24K | |
| 99051 | <1% | 2,308 | $24K | |
| 90710 | <1% | 1,027 | $23K | |
| 90707 | <1% | 1,009 | $23K | |
| 90700 | <1% | 998 | $23K | |
| 92587 | <1% | 1,006 | $21K | |
| 90677 | <1% | 926 | $21K | |
| 90696 | <1% | 891 | $20K | |
| 90619 | <1% | 961 | $20K | |
| 99382 | <1% | 166 | $19K | |
| 87807 | <1% | 1,627 | $17K | |
| 0002A | <1% | 448 | $17K | |
| 0001A | <1% | 445 | $16K | |
| 99401 | <1% | 2,583 | $15K | |
| 99050 | <1% | 957 | $11K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 95 | $10K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 57 | $10K |
| 0003A | <1% | 159 | $6K | |
| 85018 | <1% | 3,350 | $6K | |
| 86403 | <1% | 665 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 29 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 327 | $4K |
| 90480 | <1% | 109 | $4K | |
| 94010 | <1% | 141 | $4K | |
| 90661 | <1% | 246 | $4K | |
| 87400 | <1% | 298 | $3K | |
| 94760 | <1% | 3,220 | $3K | |
| 81002 | <1% | 1,165 | $3K | |
| 0124A | <1% | 66 | $3K | |
| 90381 | <1% | 47 | $2K | |
| 90688 | <1% | 117 | $2K | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 311 | $2K |
| 84030 | <1% | 732 | $1K | |
| 0154A | <1% | 37 | $1K | |
| 81025 | <1% | 182 | $1K | |
| 90380 | <1% | 24 | $942.32 | |
| 91320 | <1% | 37 | $876.06 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 59 | $825.74 |
| 0081A | <1% | 22 | $800.00 | |
| 90744 | <1% | 34 | $791.52 | |
| 36416 | <1% | 2,944 | $691.00 | |
| 0074A | <1% | 21 | $640.00 | |
| 99001 | <1% | 1,777 | $360.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $329.56 |
| 92567 | <1% | 14 | $261.49 | |
| 90687 | <1% | 12 | $256.08 | |
| 96380 | <1% | 27 | $229.08 | |
| 99072 | <1% | 1,427 | $168.00 | |
| 90658 | <1% | 12 | $164.16 | |
| 96381 | <1% | 36 | $133.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 26 | $39.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 302 | $18.23 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 13 | $9.00 |
| 91300 | <1% | 307 | $0.13 | |
| 91315 | <1% | 31 | $0.11 | |
| 91307 | <1% | 332 | $0.01 | |
| 91312 | <1% | 15 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 4,490 | $0.00 |
| G9920 | Screening performed and negative | 0% | 2,058 | $0.00 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 718 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 43 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 75 | $0.00 |
| 90461 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIMPEDUGLIA, GIOVANNI (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| White Oak Pediatrics DRS Battiata & Impeduglia PA | New Market, MD | $630K |
| White Oak Pediatrics, DRS. Battiata & Impeduglia, P.A. | New Market, MD | $73K |
| White Oak Pediatrics DRS Battiata & Impeduglia PA | Silver Spring, MD | $54K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.